Spots Global Cancer Trial Database for LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Official Title: LYNPARZA Tablets 100 mg, 150mg General Drug Use-results Study in Patients on Maintenance Treatment After Platinum-based Chemotherapy for BRCA Mutated Curatively Unresectable Pancreas Cancer
Study ID: NCT04889404
Conditions
Interventions
Study Description
Brief Summary: To collect and characterise the incidence of adverse events related to the safety specifications of the maintenance treatment after platinum-based chemotherapy in patients with BRCA mutated pancreatic cancer under the actual post-marketing use of LYNPAZA.
Detailed Description: To collect and characterise the incidence of adverse events related to the safety specifications\*1 of the maintenance treatment after platinum-based chemotherapy in patients with BRCA mutated pancreatic cancer under the actual post-marketing use of LYNPAZA. This investigation will be conducted for application for re-examination specified in Article 14-4 of the Pharmaceutical Affairs Law. \*1: Bone marrow depression, interstitial lung disease, new primary malignancies, and embryofoetal toxicity
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Osaka, Lyn010001, Japan
Research Site, Kanagawa, Lyn010003, Japan
Research Site, Okayama, Lyn010004, Japan
Research Site, Akita, Lyn010005, Japan
Research Site, Niigata, Lyn010006, Japan
Research Site, Shizuoka, Lyn010007, Japan
Research Site, Niigata, Lyn010008, Japan
Research Site, Tokyo, Lyn010009, Japan
Research Site, Saitama, Lyn010010, Japan
Research Site, Aichi, Lyn010011, Japan
Research Site, Osaka, Lyn010012, Japan
Research Site, Tokyo, Lyn010013, Japan
Research Site, Nara, Lyn010014, Japan
Research Site, Wakayama, Lyn010015, Japan
Research Site, Miyagi, Lyn010016, Japan
Research Site, Tokyo, Lyn010017, Japan
Research Site, Osaka, Lyn010018, Japan
Research Site, Gunma, Lyn010019, Japan
Research Site, Hiroshima, Lyn010020, Japan
Research Site, Tochigi, Lyn010021, Japan
Research Site, Iwate, Lyn010022, Japan
Research Site, Osaka, Lyn010025, Japan
Research Site, Shizuoka, Lyn010026, Japan
Research Site, Nagasaki, Lyn010027, Japan
Research Site, Kumamoto, Lyn010028, Japan
Research Site, Saitama, Lyn010029, Japan
Research Site, Nagano, Lyn010031, Japan
Research Site, Hyogo, Lyn010032, Japan
Research Site, Shimane, Lyn010033, Japan
Research Site, Hyogo, Lyn010034, Japan
Research Site, Shizuoka, Lyn010035, Japan
Research Site, Hyogo, Lyn010036, Japan
Research Site, Okayama, Lyn010038, Japan
Research Site, Fukuoka, Lyn010041, Japan
Research Site, Hokkaido, Lyn010042, Japan
Research Site, Ehime, Lyn010044, Japan
Research Site, Osaka, Lyn010045, Japan
Research Site, Shizuoka, Lyn010047, Japan
Research Site, Tokyo, Lyn010050, Japan
Research Site, Aichi, , Japan
Research Site, Chiba, , Japan
Research Site, Fukuoka, , Japan
Research Site, Gunma, , Japan
Research Site, Hiroshima, , Japan
Research Site, Hokkaido, , Japan
Research Site, Hyogo, , Japan
Research Site, Hyogo, , Japan
Research Site, Ibaraki, , Japan
Research Site, Kagawa, , Japan
Research Site, Kanagawa, , Japan
Research Site, Kyoto, , Japan
Research Site, Kyoto, , Japan
Research Site, Nagano, , Japan
Research Site, Nagano, , Japan
Research Site, Nagasaki, , Japan
Research Site, Nara, , Japan
Research Site, Okayama, , Japan
Research Site, Osaka, , Japan
Research Site, Shizuoka, , Japan
Research Site, Tokyo, , Japan
Research Site, Tottori, , Japan
Research Site, Toyama, , Japan
Research Site, Yamagata, , Japan
Contact Details
Name: Toshimitsu Tokimoto
Affiliation: Astrazeneca KK
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
